Kenya Ragland
Acute Care · Atlanta, GANPI 1598066011
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.3% of the total across 106 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 18.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,353 and has fallen 87.5% since, to $170 in 2025. Among acute care clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 106 payments — averaging $40.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$809
- AstraZeneca$397
- AbbVie$352
- E.r. Squibb & Sons, L.L.C.$337
- Takeda Pharmaceuticals U.S.A., Inc.$230
- Bristol Myers Squibb$227
- plus $2K from 26 others
What the payments were for
- Food & beverage$4,07495%
- Education$1995%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 15 | $809 |
| AstraZeneca(2 entities) | 5 | $397 |
| AbbVie | 7 | $352 |
| E.r. Squibb & Sons, L.L.C. | 3 | $337 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $230 |
| Bristol Myers Squibb | 10 | $227 |
| Incyte Corporation | 5 | $201 |
| Daiichi Sankyo Inc. | 5 | $190 |
| Sanofi | 4 | $184 |
| Novartis | 7 | $163 |
| Merck | 8 | $161 |
| Seagen Inc. | 3 | $152 |
| Genentech USA, Inc. | 3 | $144 |
| Gilead | 2 | $129 |
| GSK | 2 | $116 |
| Pfizer | 3 | $69 |
| Johnson & Johnson | 3 | $60 |
| Morphosys, US Inc. | 2 | $38 |
| Coherus Oncology, Inc. | 2 | $33 |
| Tersera Therapeutics LLC | 1 | $31 |
| Jazz Pharmaceuticals Inc. | 2 | $30 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $28 |
| Kyowa Kirin, Inc. | 1 | $23 |
| Servier Pharmaceuticals LLC | 1 | $22 |
| Bard Peripheral Vascular, Inc. | 1 | $21 |
| Eisai Inc. | 1 | $20 |
| Stemline Therapeutics Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $20 |
| Biolinerx USA, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $17 |
| Argenx US, Inc. | 1 | $16 |
| Organon | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,273 in reported general payments places this provider in the 90th percentile of 679 acute care providers in Georgia.
Other acute care in Atlanta
- Sarah WymanAtlanta$10K
- Ayeshia PowellAtlanta$10K
- Michael WattsAtlanta$6K
- Merry NevilleAtlanta$5K
- Annalee EdwardsAtlanta$5K
- Jamie ThreattAtlanta$5K
- Emma HallAtlanta$4K
- Gretchen HallAtlanta$4K
- Summer DaviesAtlanta$4K
- Darryl TurnerRinggold$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.